Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 18, 2019
- Revision received February 4, 2019
- Accepted February 6, 2019
- Published online March 6, 2019.
Copyright & Usage
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
Author Information
- GORDON T. BOLGER1⇑,
- ALBERT LICOLLARI1,
- RICHARD BAGSHAW1,
- AIMIN TAN1,
- RICHARD GREIL2,
- BRIGITTA VCELAR3,
- MUHAMMED MAJEED4 and
- PETER SORDILLO5⇑
- 1Nucro-Technics, Scarborough, ON, Canada
- 2Third Medical Department with Hematology and Medical Oncology, Oncologic Center Salzburg Cancer Research, Paracelsus Medical University, Institute, Cancer Cluster, Salzburg, Austria
- 3Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria
- 4Sabinsa Corporation, East Windsor, NJ, U.S.A.
- 5SignPath Pharma Inc., New York, NY, U.S.A.
- Correspondence to: Peter Sordillo SignPath Pharma, Inc., 51 East 82 Street, #1A, New York, NY 10028, U.S.A. Tel: +1 2127375706, e-mail: psordillo{at}signpathpharma.com or Gordon T. Bolger, Nucro-Technics, 2000 Ellesmere Road, Unit 16, Scarborough, Ontario, M1H 2W4, Canada. Tel: +1 4164386727, email: bolger{at}nucro-technics.com
